Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 7, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • covid world

Tag: covid world

  • BiotechToday
  • World

A drug to reduce Covid infection by 99%

BioTech Today June 29, 2021June 28, 2021 5

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University All over the world research is currently focused on the development of a drug that might help cure COVID19. At the moment we do not have any treatment for COVID19. Vaccines are the only way the chain of transmission can be broken. Throughout the pandemic, various drugs […]

Read More
  • BiotechToday
  • World

Monoclonal antibodies against SARS-CoV-2 spike protein

bioxone October 6, 2020October 6, 2020

Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]

Read More
  • BiotechToday
  • India
  • World

Elevation of serum IgA and antiphospholipid-IgA antibodies production in Severe COVID-19

bioxone October 2, 2020October 2, 2020

Anwita Sarkar, Team BioXone Based on what we know so far about the complications of COVID-19, it frequently involves complications that bear similarities to autoimmune disorders. Up to now, there are little reports on possible IgA mediated autoimmune responses. A study was conducted to determine the association of COVID-19 with vigorous total IgA responses. It […]

Read More
  • BiotechToday
  • World

COVID-19: Extracorporeal carbon dioxide removal as rescue therapy in severe Covid-19 pneumonitis

bioxone September 26, 2020September 26, 2020 9

  Srilagna Sarkar, Amity University Kolkata Coronavirus disease 2019, was first identified in Wuhan where 27 patients cases reported of pneumonia of some unknown aetiology were linked with an open seafood market. Despite several measures, the virus spread rapidly and by 11 March 2020 WHO declared it as a global pandemic. In the majority of patients […]

Read More
  • BiotechToday
  • World

COVID UPDATE: Newly discovered tiny antibodies are completely defeating the menacing coronavirus

bioxone September 16, 2020September 16, 2020

-Binayak Das,Team bioXone A team of scientists has successfully isolated what they believe to be, as being the smallest biological molecule found till date, it being approximately one-tenth the size of an average antibody molecule. They have designed a therapeutic and pre-emptive drug called- Ab8 using it, which they propose will be able to not […]

Read More
  • BiotechToday
  • FEATURED
  • Latest
  • World

Is self-quarantine a better idea?

bioxone September 13, 2020September 13, 2020

–Shrayana Ghosh, Amity University Kolkata A statement by the Centre for Disease Control and Prevention ( CDC) earlier stated that there was a comparatively higher risk of asymptomatic people being infected by COVID, which raised the number of people screened for COVID to a high level. Thousands of asymptomatic people flooded testing centers, resulting in […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy